Skip to main content
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. — Investor Relations & Filings

Ticker · WHWK ISIN · US00032Q1040 LEI · 549300G3U7TKW1M58L09 US Professional, scientific and technical activities
Filings indexed 516 across all filing types
Latest filing 2018-12-06 Director's Dealing
Country US United States of America
Listing US WHWK

About Whitehawk Therapeutics, Inc.

https://ir.whitehawktx.com/

Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2018-12-06 English
4 Filing
Director's Dealing
2018-11-30 English
4 Filing
Director's Dealing
2018-11-16 English
4 Filing
Director's Dealing
2018-11-14 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 7, 2018, reporting the financial results for the quarter ended September 30, 2018. It includes a press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The text explicitly states that the press release is furnished as an exhibit and the report is not deemed filed for certain regulatory purposes. The document length is 3123 characters, which is relatively short and consistent with an earnings release announcement rather than a full quarterly report. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2018-11-07 English
10-Q Filing
Interim / Quarterly Report 9M 2018
2018-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.